Asensus Surgical, Inc. (ASXC)
AMEX AMEX Primary 
Asensus Surgical (ASXC) Reports Q2 Loss, Tops Revenue Estimates
Asensus Surgical (ASXC) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.09 per share a year ago.
Asensus Surgical, Inc. (ASXC) Q2 2024 Earnings Call Transcript
Asensus Surgical, Inc. (NYSE:ASXC ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Mark Klausner - IR, Westwicke Partners Anthony Fernando - President and CEO Shameze Rampertab - CFO Conference Call Participants Operator Good afternoon, ladies and gentlemen, and welcome to Asensus Surgical Incorporated Second Quarter Financial and Operating Results Call. At this time, all lines are in listen-only mode.
Asensus Surgical (ASXC) Announces New Hospital Tie-Up on Senhance
Asensus Surgical (ASXC) announces an agreement with St. Marianna University School of Medicine Yokohama City Seibu Hospital to lease its Senhance Surgical System.
Asensus Surgical (ASXC) Inks a Merger Agreement With KARL STORZ
KARL STORZ is set to acquire all of the outstanding shares of Asensus Surgical (ASXC) for $0.35 per share in cash, making Asensus a subsidiary of KARL STORZ.
